Sensorimotor upper limb therapy does not improve somatosensory function and may negatively interfere with motor recovery: a randomized controlled trial in the early rehabilitation phase after stroke

Abstract

AbstractQuestionIs sensorimotor upper limb (UL) therapy of more benefit for motor and somatosensory outcome than motor therapy?DesignRandomised assessor-blinded multi-centre controlled trial with block randomization stratified for neglect, severity of motor impairment, and type of stroke.Participants40 first-ever stroke patients with UL sensorimotor impairments admitted to the rehabilitation centreInterventionBoth groups received 16 hours of additional therapy over four weeks consisting of sensorimotor (N=22) or motor (N=18) UL therapy.Outcome measuresAction Research Arm test (ARAT) as primary outcome, and other motor and somatosensory measures were assessed at baseline, post-intervention and after four weeks follow-up.ResultsNo significant between-group differences were found for change scores in ARAT or any somatosensory measure between the three time points. For UL impairment (Fugl-Meyer assessment), a significant greater improvement was found for the motor group compared to the sensorimotor group from baseline to post-intervention (mean (SD) improvement 14.65 (2.19) versus 5.99 (2.06); p=0.01) and from baseline to follow-up (17.38 (2.37) versus 6.75 (2.29); p=0.003).ConclusionUL motor therapy may improve motor impairment more than UL sensorimotor therapy in patients with sensorimotor impairments in the early rehabilitation phase post stroke. For these patients, integrated sensorimotor therapy may not improve somatosensory function and may negatively influence motor recovery.Trial registrationThe trial is registered at clinicaltrials.gov NCT03236376.